FDA Approves Sorilux for Adolescent Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
Integrating retail skincare into plastic surgery practices improves patient outcomes, boosts satisfaction, and supports healing. By offering medical-grade products tailored to each procedure, surgeons can provide comprehensive care while enhancing practice revenue and reputation. Learn how skincare aligns with surgical results to set new standards in patient care and practice growth.